Giuseppe
Emeritus
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus (N Engl J Med., 1st paragraph, edited)
[Source: New England Journal of Medicine, full free text: <cite cite="http://www.nejm.org/doi/full/10.1056/NEJMc1003749?query=TOC">Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus ? NEJM</cite>. 1st paragraph, edited.]
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus
N Engl J Med 2010; 363:1381-1382
September 30, 2010
To the Editor:
Since the outbreak of influenza A (H1N1) virus pandemic, almost 300 cases of infection with an oseltamivir-resistant influenza virus have been reported to the World Health Organization as of June 2010.1 These strains typically contain a single histidine-to-tyrosine substitution at position 275 (H275Y) of the viral neuraminidase, but they remain susceptible to zanamivir. Successful clearance of an oseltamivir-resistant virus with zanamivir, the other approved neuraminidase inhibitor, has been reported.2 We report the emergence of a pandemic influenza virus in a patient treated with neuraminidase inhibitors, with a novel resistance pattern that conferred resistance to oseltamivir, zanamivir, and peramivir.
(...)
-
------<cite cite="http://www.nejm.org/doi/full/10.1056/NEJMc1003749?query=TOC"></cite>
[Source: New England Journal of Medicine, full free text: <cite cite="http://www.nejm.org/doi/full/10.1056/NEJMc1003749?query=TOC">Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus ? NEJM</cite>. 1st paragraph, edited.]
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus
N Engl J Med 2010; 363:1381-1382
September 30, 2010
To the Editor:
Since the outbreak of influenza A (H1N1) virus pandemic, almost 300 cases of infection with an oseltamivir-resistant influenza virus have been reported to the World Health Organization as of June 2010.1 These strains typically contain a single histidine-to-tyrosine substitution at position 275 (H275Y) of the viral neuraminidase, but they remain susceptible to zanamivir. Successful clearance of an oseltamivir-resistant virus with zanamivir, the other approved neuraminidase inhibitor, has been reported.2 We report the emergence of a pandemic influenza virus in a patient treated with neuraminidase inhibitors, with a novel resistance pattern that conferred resistance to oseltamivir, zanamivir, and peramivir.
(...)
-
------<cite cite="http://www.nejm.org/doi/full/10.1056/NEJMc1003749?query=TOC"></cite>